Skip to content

HEALTHTECH SOLUTIONS, INC./UT: 10-Q filed 2022-11-23

What HEALTHTECH SOLUTIONS, INC./UT reported in its quarterly report filed 2022-11-23 (fiscal Q3 2022): 40 published measures, 97 facts as tagged in accession 0001262463-22-000147.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-23
Fiscal period
fiscal Q3 2022
Accession
0001262463-22-000147 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HEALTHTECH SOLUTIONS, INC./UT filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-301,637,460USD
At 2021-12-31423,102USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-304,488,588USD
At 2021-12-311,070,665USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-30-2,339,741USD
At 2021-12-31-647,563USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-30192,006USD
At 2021-12-317,105USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-736,075USD92
2022-01-01 to 2022-09-30-2,177,592USD273
2021-07-01 to 2021-09-30-1,201,764USD92
2021-01-01 to 2021-09-30-6,269,511USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-1,985,730USD273
2021-01-01 to 2021-09-30-1,570,582USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-07-01 to 2022-09-30776,221USD92
2022-01-01 to 2022-09-30776,221USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-302,170,631USD273
2021-01-01 to 2021-09-301,917,600USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-437,055USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-12,662,603USD
At 2021-12-31-10,547,924USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3067,334,064shares92
2022-01-01 to 2022-09-3067,089,094shares273
2021-07-01 to 2021-09-3029,145,933shares92
2021-01-01 to 2021-09-3019,932,187shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.01USD/shares92
2022-01-01 to 2022-09-30-0.04USD/shares273
2021-07-01 to 2021-09-30-0.04USD/shares92
2021-01-01 to 2021-09-30-0.31USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-3093,333USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-301,029,028USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-844,921USD92
2022-01-01 to 2022-09-30-2,626,066USD273
2021-07-01 to 2021-09-30-1,205,164USD92
2021-01-01 to 2021-09-30-2,973,242USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-301,327,235USD
At 2021-12-31313,102USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-01-01 to 2021-09-30367,144USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-304,488,588USD
At 2021-12-311,070,665USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-09-30106,892USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-30720,777USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,569,308USD92
2022-01-01 to 2022-09-303,350,452USD273
2021-07-01 to 2021-09-301,205,164USD92
2021-01-01 to 2021-09-302,973,242USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-09-30198,535USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-30724,387USD92
2022-01-01 to 2022-09-30724,387USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-07-01 to 2022-09-3051,834USD92
2022-01-01 to 2022-09-3051,834USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-30415,947USD92
2022-01-01 to 2022-09-301,394,596USD273
2021-07-01 to 2021-09-30150,130USD92
2021-01-01 to 2021-09-30346,864USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3069,965,933shares
At 2021-12-3169,965,933shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-09-30192,006USD
At 2021-12-317,105USD
At 2021-09-3038,959USD
At 2020-12-31128,996USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-3010,252,786USD
At 2021-12-319,833,286USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2022-09-30-2,851,128USD
At 2022-06-30-2,428,707USD
At 2022-03-31-1,448,908USD
At 2021-12-31-647,563USD
At 2021-09-30-12,464USD
At 2021-06-301,192,700USD
At 2021-03-31-851,915USD
At 2020-12-31-562,597USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-844,921USD92
2022-01-01 to 2022-09-30-2,626,066USD273
2021-07-01 to 2021-09-30-1,205,164USD92
2021-01-01 to 2021-09-30-6,274,121USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-844,921USD92
2022-01-01 to 2022-09-30-2,626,066USD273
2021-07-01 to 2021-09-30-1,205,164USD92
2021-01-01 to 2021-09-30-6,274,121USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-844,921USD92
2022-04-01 to 2022-06-30-979,799USD91
2022-01-01 to 2022-03-31-801,345USD90
2021-07-01 to 2021-09-30-1,205,164USD92
2021-04-01 to 2021-06-30-4,775,080USD91
2021-01-01 to 2021-03-31-293,877USD90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,031,408USD92
2022-01-01 to 2022-09-301,672,149USD273
2021-07-01 to 2021-09-30938,052USD92
2021-01-01 to 2021-09-301,870,403USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-09-3026,667USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-01-01 to 2022-09-3030,540USD273
2021-01-01 to 2021-09-3025,926USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-3,300,879USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-3061USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-09-301,792,500USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30776,221USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30220,713USD273

Inspect the source

Entity
HEALTHTECH SOLUTIONS, INC./UT / CIK 0001307624
Captured
SEC response SHA-256
f5d1c561c589c61f12103ed9b73d17e9d0fa0b9efd61135572ca7ec1fdf07b18

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001307624.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))